A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD

Trial Profile

A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD

Withdrawn prior to enrolment
Phase of Trial: Phase I/II

Latest Information Update: 30 Sep 2016

At a glance

  • Drugs Mannitol (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Pharmaxis
  • Most Recent Events

    • 30 Sep 2016 New trial record
    • 27 Sep 2016 Status changed from completed to withdrawn prior to enrolment because fail to recruit.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top